跳到主要內容

Yancopoulos George 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2023/3/27 申報

申報編號
0001883850-23-000062
申報時間
2023/3/27
交易日
2023/3/23
申報延遲
4 天
10b5-1 計畫
有勾選

這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $294.0 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Yancopoulos GeorgeCIK 0001226690董事、高階主管(President and Chief Scientific)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/3/23Common StockS賣出處分−254$800.59F2−$203,349.86200,250間接
2023/3/23Common StockS賣出處分−122$801.16F4−$97,741.52200,128間接
2023/3/23Common StockS賣出處分−1,237$802.54F5−$992,741.98198,891間接
2023/3/23Common StockS賣出處分−642$803.30F6−$515,718.6198,249間接
2023/3/23Common StockS賣出處分−254$804.38F7−$204,312.52197,995間接
2023/3/23Common StockS賣出處分−47$805.55−$37,860.85197,948間接
2023/3/23Common StockS賣出處分−700$806.47−$564,529197,248間接
2023/3/23Common StockS賣出處分−400$810.30−$324,120196,848間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $800.52 to $800.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 122 shares of Company stock on March 23, 2023 at prices ranging from $801.00 to $801.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 1,237 shares of Company stock on March 23, 2023 at prices ranging from $802.00 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 642 shares of Company stock on March 23, 2023 at prices ranging from $803.01 to $803.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $804.00 to $804.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)